Document:

EX-10.3

 Exhibit 10.3 

EXECUTION VERSION 
 NISSAN
MOTOR ACCEPTANCE CORPORATION, 
 as Grantor and Beneficiary, 

U.S. BANK TRUST NATIONAL ASSOCIATION, 

as Trustee, 
 NISSAN MOTOR
ACCEPTANCE CORPORATION, 
 as Administrator 

and 
 WILMINGTON TRUST COMPANY,

 as Delaware Trustee 
  

 
 FIRST AMENDMENT
TO 
 AMENDED AND RESTATED TRUST AGREEMENT 

Dated as of March 19, 2021 

 FIRST AMENDMENT TO AMENDED AND RESTATED TRUST AGREEMENT 

This First Amendment (this “Amendment”) to the Amended and Restated Trust Agreement is dated as of March 19, 2021, and
is entered into by and between Nissan Motor Acceptance Corporation (“NMAC”), as Grantor and Beneficiary, and as Administrator, U.S. Bank Trust National Association, as Trustee, and Wilmington Trust Company, as Delaware Trustee.
Capitalized terms used herein that are not otherwise defined shall have the meanings ascribed thereto in the Amended and Restated Trust Agreement dated as of March 1, 1999 (the “Trust Agreement”), by and between the parties
hereto. 
 RECITALS 
 WHEREAS,
the parties hereto wish to amend the Trust Agreement pursuant to Section 10.01(b) thereof as of the Effective Date (as defined below) in accordance with the terms and conditions set forth below. 

NOW, THEREFORE, in consideration of the amendments, agreements, and other provisions herein contained and of other good and valuable
consideration, the receipt and adequacy of which are hereby acknowledged, the parties hereto agree as follows: 
 ARTICLE 1 

AMENDMENT OF THE TRUST AGREEMENT 

Section 1.01. Amendment of Section 2.07. 

(a) Section 2.07 is hereby amended by deleting paragraph (e)(ii) in its entirety and substituting in lieu thereof a new paragraph (e)(ii),
reading in its entirety as follows: 
 “commence any voluntary Proceeding with respect to the Trust under any United States federal or
State bankruptcy or similar law without the prior written consent of the Trustee, each Holder and, if any Rated Securities are outstanding, the satisfaction of the Rating Agency Condition; or” 

(b) Section 2.07 is hereby further amended by deleting paragraph (h) in its entirety and substituting in lieu thereof a new paragraph
(h), reading in its entirety as follows: 
 “The Trust shall not merge or consolidate with, or sell all or substantially all of the
Trust Assets to any Person, except in accordance with the Relevant Documents, with the prior written consent of each Holder and, if any Rated Securities are Outstanding, with the satisfaction of the Rating Agency Condition. Without limiting the
generality of the foregoing, the Trustee shall not delegate any decision with regard to any merger, consolidation, sale of assets, the filing by the Trust of a voluntary petition for bankruptcy or consenting to the filing of an involuntary petition
for bankruptcy against the Trust.” 

 Section 1.02. Amendment of Section 4.04. Section 4.04 is hereby
amended by deleting such Section in its entirety and substituting in lieu thereof a new Section, reading in its entirety as follows: 

“The Trustee shall not have the power to commence a voluntary Proceeding with respect to the Trust under any United States federal or
State bankruptcy or similar law without the prior written consent of each Holder and if any Rated Securities are outstanding, the satisfaction of the Rating Agency Condition.” 

Section 1.03. Amendment of Section 10.08. Section 10.08 is hereby amended by deleting paragraph (b) in its
entirety and substituting in lieu thereof a new paragraph (b), reading in its entirety as follows: 
 “Each of the Trustee and Delaware
Trustee, by entering into this Agreement, hereby covenants and agrees that they will not at any time institute against the Beneficiary, the Administrator or the Trust, or join in any institution against the Beneficiary, the Administrator or the
Trust of, any bankruptcy Proceedings under any United States federal or State bankruptcy or similar law in connection with any obligations relating to this Agreement or any Trust Document; provided, however, that upon receipt of the written consent
of each Holder and, if any Rated Securities are outstanding, the satisfaction of the Rating Agency Condition, each of the Trustee and the Delaware Trust may file such a Proceeding against the Trust.” 

Section 1.04. Amendment of Exhibit A. Section 2.07 is hereby further amended by deleting the definition of “Rating Agency
Condition” in its entirety and substituting in lieu thereof a new definition of “Rating Agency Condition”, reading in its entirety as follows: 

“ “Rating Agency Condition” means, with respect to any event or action and each Rating Agency, either (a) written
confirmation (which may be in the form of a letter, a press release or other publication, or a change in such Rating Agency’s published ratings criteria to this effect) by such Rating Agency that the occurrence of such event or action will not
cause it to downgrade, qualify or withdraw its rating assigned to any Rated Securities or (b) that such Rating Agency shall have been given notice of such event or action at least ten (10) days prior to such event or action (or, if ten
(10) days’ advance notice is impracticable, as much advance notice as is practicable) and such Rating Agency shall not have issued any written notice that the occurrence of such event or action will cause it to downgrade, qualify or
withdraw its rating assigned to any Rated Securities.” ” 

 ARTICLE 2 

EFFECTIVE DATE 

Section 2.01. Effective Date. Upon receipt by NMAC of counterparts of this Amendment executed by the Grantor, the Beneficiary, the
Administrator, the Trustee and the Delaware Trustee, this Amendment shall become effective immediately after all of the following occur (such date, the “Effective Date”), without further action by any party other than the following:

 (a) prior written consent of each Holder with respect to this Amendment in accordance with Section 10.01(b) of the Trust Agreement;

 (b) satisfaction of the Rating Agency Condition with respect to this Amendment in accordance with Section 10.01(b) of the Trust
Agreement; and 
 (c) receipt by the Trustee of an Opinion of Counsel in accordance with Section 10.01(f) of the Trust Agreement. 

Upon receipt of evidence of satisfaction of the conditions set forth above, NMAC shall provide written notice to the Trustee and the Delaware
Trustee stating that the conditions to effectiveness of this Amendment have been satisfied and identifying the Effective Date. 
 ARTICLE 3

 MISCELLANEOUS 

Section 3.01. Reference to and Effect on the Trust Agreement. 

(a) On or after the Effective Date, each reference in the Trust Agreement to “this Agreement,” “hereunder,”
“hereof,” “herein,” or words of similar import referring the Trust Agreement shall mean and be a reference to the Trust Agreement as amended by this Amendment. 

(b) Except as specifically amended by this Amendment, the Trust Agreement shall remain in full force and effect and is hereby ratified and
confirmed. 
 Section 3.02. Governing Law. This Amendment shall be governed by and construed in accordance with the laws of the
State of Delaware, without reference to its conflict of law provisions, and the obligations, rights and remedies of the parties hereunder shall be determined in accordance with such laws. 

Section 3.03. Direction to Delaware Trustee. NMAC hereby requests and directs that each of Wilmington Trust Company, in its
capacity as the Delaware Trustee, and U.S. Bank National Association, as Trustee, execute and deliver this Amendment. 

 Section 3.04. Counterparts; Electronic Signatures. This Amendment may be executed
(including by way of electronic or facsimile transmission) in any number of counterparts and by separate parties hereto on separate counterparts, each of which when executed shall be deemed an original, but all counterparts taken together shall
constitute one and the same instrument. The parties acknowledge and agree that they may execute this Amendment and any variation or amendment to the same, by electronic instrument. The parties agree that the electronic signatures appearing on the
document shall have the same effect as handwritten signatures and the use of an electronic signature on this Amendment shall have the same validity and legal effect as the use of a signature affixed by hand and is made with the intention of
authenticating this Amendment, and evidencing the parties’ intention to be bound by the terms and conditions contained herein. For the purposes of using an electronic signature, the parties authorize each other to the lawful processing of
personal data of the signers for contract performance and their legitimate interests including contract management. 
 [Remainder of the page
intentionally left blank.] 

 IN WITNESS WHEREOF, the parties hereto have caused this Amendment to be executed by their
respective signatories thereunto duly authorized as of the date first written above. 
  

			
	NISSAN MOTOR ACCEPTANCE CORPORATION, as Grantor and Beneficiary

 
			
		
	By:	 	 /s/ Douglas E. Gwin, Jr.

			
	Name:	 	Douglas E. Gwin, Jr.
	Title:	 	Assistant Treasurer
	
	NISSAN MOTOR ACCEPTANCE CORPORATION, as Administrator

 
			
		
	By:	 	 /s/ Douglas E. Gwin, Jr.

			
	Name:	 	Douglas E. Gwin, Jr.
	Title:	 	Assistant Treasurer

 Signature page to First Amendment To Amended And Restated Trust Agreement 

 
			
	U.S. BANK TRUST NATIONAL ASSOCIATION, as Trustee

 
			
		
	By:	 	 /s/ Brian W. Kozack

			
	Name:	 	Brian W. Kozack
	Title:	 	Vice President

 Signature page to First Amendment To Amended And Restated Trust Agreement 

 
			
	WILMINGTON TRUST COMPANY, as Delaware Trustee

 
			
		
	By:	 	 /s/ Drew H. Davis

 

			
	Name:	 	Drew H. Davis
	Title:	 	Vice President

 Signature page to First Amendment To Amended And Restated Trust Agreementfusn-ex43_899.htm

 

Exhibit 4.3

DESCRIPTION OF SECURITIES REGISTERED UNDER SECTION 12 OF THE EXCHANGE ACT

General

The following description of the capital stock of Fusion Pharmaceuticals Inc. (the “Company”) is intended as a summary only and therefore is not a complete description of the Company’s capital stock. This description is based upon, and is qualified by reference to, the Company’s Articles of Amendment to the Articles of the Company (the “Articles”), and its General By-laws (the “Bylaws”), which are filed as exhibits to the Annual Report on Form 10-K, of which this Exhibit 4.3 is a part.

The Company’s authorized share capital consists of an unlimited number of common shares, no par value, and an unlimited number of preferred shares, no par value, issuable in series, all of which preferred shares are undesignated.

Common Shares

The holders of the Company’s common shares are entitled to one vote for each share held on all matters submitted to a vote of the shareholders. Holders of the Company’s common shares are entitled to receive ratably any dividends declared by the Company’s board of directors out of funds legally available for that purpose, subject to any preferential dividend rights of any outstanding preferred shares. The Company’s common shares have no preemptive rights, conversion rights or other subscription rights or redemption or sinking fund provisions.

In the event of the Company’s liquidation, dissolution or winding up, holders of common shares will be entitled to share ratably in all assets remaining after payment of all debts and other liabilities and any liquidation preference of any outstanding preferred shares.

Preferred Shares

The Company’s board of directors has the authority, without further action by the Company’s shareholders, to issue an unlimited number of preferred shares in one or more series and to fix the rights, preferences, privileges and restrictions thereof. These rights, preferences and privileges could include dividend rights, conversion rights, voting rights, terms of redemption, liquidation preferences, sinking fund terms and the number of shares constituting, or the designation of, such series, any or all of which may be greater than the rights of common shares. The issuance of preferred shares could adversely affect the voting power of holders of common shares and the likelihood that such holders will receive dividend payments and payments upon the Company’s liquidation, dissolution or winding up. In addition, the issuance of preferred shares could have the effect of delaying, deferring or preventing a change in control of the Company or other corporate action. 

 

Canadian Business Corporations Act

 

The Company is governed by the Canada Business Corporations Act (the “CBCA”). The CBCA, the Articles and the Bylaws contain provisions that could have the effect of delaying, deferring or discouraging another party from acquiring control of the Company. These provisions are summarized below.

 

Advance Notice Provisions

 

Our Bylaws contain certain provisions that are intended to: (1) facilitate orderly and efficient annual general meetings or, where the need arises, special meetings; (2) ensure that all our shareholders receive adequate notice of board nominations and sufficient information with respect to all nominees; and (3) allow our shareholders to vote on an informed basis. Only persons who are nominated by shareholders in accordance with our advance notice provisions will be eligible for election as directors at any annual meeting of our shareholders, or at any special meeting of our shareholders if one of the purposes for which the special meeting was called was the election of directors.

 

1

 

 

Under our advance notice provisions, a shareholder wishing to nominate a director would be required to provide us with notice, in a prescribed form and within prescribed time periods. These time periods include, (1) in the case of an annual meeting of shareholders (including annual and special meetings), not less than 30 days prior to the date of the annual meeting of shareholders; provided that if the first public announcement of the date of the annual meeting of shareholders, which we refer to as the notice date, is less than 50 days before the meeting date, not later than the close of business on the 10th day following the notice date, and (2) in the case of a special meeting (which is not also an annual meeting) of shareholders called for any purpose which includes electing directors, not later than the close of business on the 15th day following the notice date; provided that, in either instance, if “notice-and-access” provisions under applicable Canadian laws are used for delivery of proxy related materials in respect of a meeting described above, and the notice date in respect of the meeting is not less than 50 days prior to the date of the applicable meeting, the notice must be received not later than the close of business on the 40th day before the applicable meeting.

 

Shareholder Nominations and Proposals

 

Under the CBCA, a registered holder or beneficial owner of shares that are entitled to be voted at an annual meeting of shareholders may submit to the corporation notice of any matter that the person proposes to raise at the meeting (a “proposal”), which is subject to any requirements in the bylaws for advance notice to the corporation. A proposal may include nominations for the election of directors if the proposal is signed by one or more holders of shares representing in the aggregate not less than five per cent of the issued and outstanding shares or five per cent of the issued and outstanding shares of a class of shares of the corporation entitled to vote at the meeting to which the proposal is to be presented, but this subsection does not preclude nominations made at a meeting of shareholders.

 

Shareholder Actions by Written Consent

 

Under the CBCA, shareholders may act by written resolution signed by all the shareholders entitled to vote on that resolution at a meeting of shareholders.

 

Amendment to Articles and Bylaws

 

Under the CBCA, either a director or a shareholder entitled to vote at an annual or special meeting of shareholders may make a proposal to amend the Articles. A proposed amendment to the Articles requires approval by special resolution of the shareholders. A special resolution is a resolution passed by not less than two-thirds of the votes cast by the shareholders who voted in respect of the resolution or signed by all shareholders entitled to vote on that resolution.

 

Under the CBCA, a shareholder entitled to vote at an annual or special meeting of shareholders may make a proposal to make, amend or repeal a by-law. Unless the Articles, Bylaws or a unanimous shareholder agreement otherwise provide, the directors may, by resolution, make, amend or repeal any Bylaws that regulate the business or affairs of the corporation. The directors shall then submit such by-law, or amendment or repeal of such by-law, to the shareholders at the next meeting of shareholders, and the shareholders may, confirm, reject or amend the by-law, amendment or repeal by ordinary resolution.

 

Votes on Mergers, Consolidations and Sale of Assets

 

Under the CBCA, the approval of an amalgamation agreement and certain other transactions requires approval by special resolution. A special resolution is a resolution passed by not less than two-thirds of the votes cast by the shareholders who voted in respect of the resolution or signed by all shareholders entitled to vote on that resolution.

 

Anti-Takeover and Ownership Provisions

 

The CBCA contains no restriction on the adoption of a shareholder rights plan. The CBCA does not restrict related party transactions; however, in Canada, takeover bids and related party transactions are addressed in provincial securities legislation and policies.

 

 

2

 

 

 

Transactions with Directors and Officers

 

Under the CBCA, a director or an officer of a corporation shall disclose to the corporation, in writing or by requesting to have it entered in the minutes of meetings of directors or of meetings of committees of directors, the nature and extent of any interest that he or she has in a material contract or material transaction, whether made or proposed, with the corporation, if the director or officer (i) is a party to the contract or transaction; (ii) is a director or an officer, or an individual acting in a similar capacity, of a party to the contract or transaction; or (iii) has a material interest in a party to the contract or transaction.

Stock Exchange Listing

The Company’s common shares are listed on The Nasdaq Global Select Market under the trading symbol “FUSN.”

Transfer Agent and Registrar

The Transfer Agent and Registrar for the Company’s common shares is American Stock Transfer & Trust Company, LLC.

 

3

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00324-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00324-of-00352.parquet"}]]